Welcome to our dedicated page for DOCUSIGN SEC filings (Ticker: DOCU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on DOCUSIGN's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into DOCUSIGN's regulatory disclosures and financial reporting.
DOCUSIGN, INC. (DOCU) director Teresa Briggs filed a Rule 144 notice for a planned sale of common stock. The notice covers up to 548 shares of DOCU common stock to be sold through Morgan Stanley Smith Barney LLC on NASDAQ, with an aggregate market value of $35,400.80 as reported. The shares are described as restricted stock acquired from the issuer on February 28, 2025.
DOCUSIGN, INC. (DOCU) has a notice under Rule 144 for proposed sales of common stock held for the account of director Peter Solvik30,000 shares, 8,000 shares, and another 8,000 shares of Docusign common stock through Merrill Lynch.
These shares come from multiple pre-IPO investments by Sigma Partners in Docusign common stock acquired between March 2006 and October 2014. The approximate date of sale for the listed blocks is September 10, 2026, and the filing identifies Docusign’s common stock as listed on NASDAQ.
DOCUSIGN, INC. reported that its Chief Financial Officer, Blake Jeffrey Grayson, sold shares of the company’s common stock in open-market transactions. On September 4, 2026, he sold 30,000 shares at a reported price of $70.00 per share. On September 8, 2026, he sold 11,550 shares at $65.25 per share and 3,450 shares at $66.64 per share, for a total of 45,000 shares sold. All sales were made pursuant to a Rule 10b5-1 plan, and the reported prices for two of the transactions are accompanied by ranges indicating the shares were sold at prices within the stated intervals.
DOCUSIGN, INC. (DOCU) director Brian Keith Roberts reported the exercise of 856 Restricted Stock Units (RSUs) into 856 shares of Common Stock on September 5, 2026, at a stated price of $0.00 per share. Following this conversion, he held 1,711 shares of Common Stock directly.
The exercised RSUs each represent a contingent right to receive one share of DOCU common stock. After this transaction, Roberts also held 8,558 RSUs, which are scheduled to vest in twelve equal quarterly installments over three years, with a vesting commencement date of March 5, 2026, subject to his continued service. The RSUs do not have an expiration date; they either vest or are canceled. No Rule 10b5-1 trading plan is reported for these transactions.
DOCUSIGN, INC. (DOCU) reported that its Chief Financial Officer, Blake Jeffrey Grayson, sold a total of 45,000 shares of common stock in open-market transactions. The sales occurred on September 4, 2026 and September 8, 2026, and were affirmed as made under a Rule 10b5-1 trading plan.
DOCUSIGN, INC. (DOCU) received a notice under Rule 144 that officer Blake J. Grayson intends to sell 15,000 shares of common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value listed as $983,547. The notice states that DOCUSIGN had 186,902,452 shares of common stock outstanding. The securities to be sold were acquired upon the vesting of restricted stock during the period from June 10, 2024 through September 10, 2024.
The filing also reports that Blake J. Grayson sold DOCUSIGN common stock during the prior three months, including 30,000 shares for $2,100,000 on September 4, 2026, 15,000 shares for $900,000 on August 7, 2026, and 15,000 shares for $683,238 on July 1, 2026.
Docusign, Inc. (DOCU) reported solid growth and profitability for the quarter ended July 31, 2026. Revenue for the quarter rose 9% year over year to $875.7 million, driven mainly by expansion in commercial and enterprise accounts and its digital channel. GAAP operating margin improved to 13.4% from 8.1%, and net income for the quarter increased to $77.7 million.
For the first six months of fiscal 2027, revenue grew 9% to $1.71 billion, with international revenue up 17%. Free cash flow for the period was strong at $585.2 million, a 34% margin, while cash, cash equivalents, restricted cash and investments totaled $990.4 million. DocuSign repurchased 13.3 million shares for $624.0 million, reducing share count, and continues to operate with no borrowings under its $750 million revolving credit facility. The company highlights growth in its AI-native Intelligent Agreement Management platform, which reached 15.1% of total ARR.
DOCUSIGN, INC. (DOCU) has a notice of proposed resale of restricted securities by officer Blake J. Grayson under Rule 144. The filing covers the potential sale of 30,000 shares of common stock through Morgan Stanley Smith Barney, with an estimated aggregate sale price of $2,100,000.
The shares to be sold were acquired upon the vesting of Restricted Stock and Performance Shares during the period from August 10, 2025 through March 10, 2026. The notice also reports prior sales in the last three months, including 15,000 shares for $900,000 on August 7, 2026 and 15,000 shares for $683,238 on July 1, 2026.
DOCUSIGN, INC. (DOCU) director Enrique T Salem reported the exercise and conversion of 1,096 Restricted Stock Units into 1,096 shares of common stock on September 1, 2026, at a stated price of $0.00 per share. Following the transactions, he holds 168,414 common shares and 3,288 RSUs directly. Each RSU represents a contingent right to receive one share of common stock, with the RSUs vesting in equal quarterly installments over one year starting June 1, 2026, subject to continued service. No Rule 10b5-1 trading plan is reported.
DOCUSIGN, INC. (DOCU) director Michael George Rosenbaum reported the exercise of 522 Restricted Stock Units into an equal number of shares of common stock on September 3, 2026. Following this RSU conversion, he holds 2,088 common shares and 4,177 RSUs directly. The RSUs vest in twelve equal quarterly installments over three years starting September 3, 2025, and either vest or are canceled; no Rule 10b5-1 trading plan is reported.